Acetylated starch nanocrystals: Preparation and antitumor drug delivery study

International Journal of Biological Macromolecules

Volumn 89, Issue , 2016, Pages 456-464

  Xiao, Huaxi ^a   Yang, Tao ^a   Lin, Qinlu ^a   Liu, Gao Qiang ^a   Zhang, Lin ^a   Yu, Fengxiang ^b   Chen, Yuejiao ^a  

^a CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

^b Research Institute of Vine Plant   (China)

Author keywords

Acetylated starch nanoparticles; Broken rice; Drug delivery

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLATED STARCH NANOCRYSTAL; DOXORUBICIN; NANOCRYSTAL; UNCLASSIFIED DRUG; ACETIC ANHYDRIDE; ANTINEOPLASTIC AGENT; NANOPARTICLE; STARCH;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG RESPONSE; DRUG UPTAKE; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH MEASUREMENT; ACETYLATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; LIVER CELL; NEOPLASMS; RAT;

ACETIC ANHYDRIDES; ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HELA CELLS; HEPATOCYTES; HUMANS; NANOPARTICLES; NEOPLASMS; RATS; STARCH;

EID: 84968626423     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.04.037     Document Type: Article

References (28)

1. Chan P.S.K., Chen J.S., Ettelaie R., Law Z., Alevisopoulos S., Day E., Smith S. Study of the shear and extensional rheology of casein, waxy maize starch and their mixtures. Food Hydrocolloid 2007, 21:716-725.
2. Mundargi R.C., Shelke N.B., Rokhade A.P., Patil S.A., Aminabhavi T.M. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohydr. Res. 2008, 71:42-53.
3. Mao S.R., Chen Z.M., Wei Z.P., Liu H., Bi D.Z. Intranasal administration of melatonin starch microspheres. Int. J. Phytorem. 2004, 272:37-43.
4. Herman J., Remon J.P. Modified starches as hydrophilic matrices for controlled oral delivery: II. In-vitro drug release evaluation of thermally modified starches. Int. J. Phytorem. 1989, 56:65-70.
5. Fang Y., Wang L., Li D., Li B.Z., Bhandari B., Chen X.D., Mao Z.H. Preparation of crosslinked starch microspheres and their drug loading and releasing properties. Carbohydr. Polym. 2008, 74:379-384.
6. Tuovinent L., Peltonen S., Järvinen K. Drug release from starch-acetate films. J. Controlled Release 2003, 91:345-354.
7. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 1999, 57:727-741.
8. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., Lübbe A.S. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000, 60:6641-6648.
9. Prasad P., Cheng J., Shuhendler A., Rauth A.M., Wu X.Y. A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells. Drug. Deliv. Transl. Res. 2012, 2:1-11.
10. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 2000, 65:271-284.
11. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41:189-207.
12. Wike-Hooley J., Haveman J., Reinhold H. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 1984, 2:343-366.
13. Angellier H., Choisnard L., Molina-Boisseau S., Ozil P., Dufresne A. Optimization of the preparation of aqueous suspensions of waxy maize SN using a response surface methodology. Biomacromolecules 2004, 5:1545-1551.
14. Singh J., McCarthy O.J., Singh H. Physicochemical and morphological characteristics of New Zealand Taewa (Maori potato) starches. Carbohydr. Polym. 2006, 64:569-581.
15. Teixeira R.S.S., da Silva A.S., Ferreira-Leitao V.S., da Silva Bon E.P. Amino acids interference on the quantification of reducing sugars by the 3,5-dinitrosalicylic acid assay mislead carbohydrase activity measurements. Carbohydr. Res. 2012, 363:33-37.
16. Blennow A., Hansen M., Schulz A., Jorgensen K., Donald A.M., Sanderson J. The molecular deposition of transgenically modified starch in the starch granule as imaged by functional microscopy. J. Struct. Biol. 2003, 143:229-241.
17. Shalviri A., Raval G., Prasad P., Chan C., Liu Q., Heerklotz H., Rauth A.M., Wu X.Y. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. Eur. J. Pharm. Biopharm. 2012, 82:587-597.
18. Huang Y.J., Liu M.Z., Gao C.M., Yang J., Zhang X., Zhang X., Liu Z. Ultra-small and innocuous cationic starch nanospheres: preparation, characterization and drug delivery study. Int. J. Biol. Macromol. 2013, 58:231-239.
19. Govender T., Riley T., Ehtezazi T., Garnett M.C., Stolnik S., Illum L., Davis S.S. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm. 2000, 199:95-110.
20. Chen Y., Mohanraj V.J., Parkin J.E. Chitosan-dextran sulfate nanoparticles for delivery of an antiangiogenesis peptide. Lett. Pept. Sci. 2003, 10:621-629.
21. Pego A.P., Poot A.A., Grijpma D.W., Feijen J. Copolymers of trimethylene carbonate and epsilon-caprolactone for porous nerve guides: synthesis and properties. J. Biomat. Sci. Polym. E 2001, 12:35-53.
22. Dobrzynski P., Kasperczyk J. Synthesis of biodegradable copolymers with low-toxicity zirconium compounds. V. multiblock and random copolymers of l-lactide with trimethylene carbonate obtained in copolymerizations initiated with zirconium zirconium(IV) acetylacetonate. J. Polym. Sci. Part A: Polym. Chem. 2006, 44:3184-3201.
23. Fringant C., Desbrières J., Rinaudo M. Physical properties of acetylated starch-based materials: relation with their molecular characteristics. Polymers 1996, 37:2663-2673.
24. Shuhendler A.J., Cheung R.Y., Manias J., Connor A., Rauth A.M., Wu X.Y. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells. Breast Cancer Res. Treat. 2004, 119:255-269.
25. O'Brien P.J., Chan K., Silber P.M. Human and animal hepatocytes in vitro with extrapolation in vivo. Chem. Biol. Interact. 2004, 150:97-114.
26. Marques A.P., Reis R.L., Hunt J.A. The biocompatibility of novel starch-based polymers and composites: in vitro studies. Biomaterials 2002, 23:1471-1478.
27. Behne M., Thomas H., Bremerich D.H., Lischke V., Asskali F., Förster H. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery. Anesth. Analg. 1998, 86:856-860.
28. Korhonen O., Kanerva H., Vidgren M., Urtti A., Ketolainen J. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers. J. Controlled Release 2004, 95:515-520.